Janssen Ad26.CoV2.S Vaccine Booster in Kidney Transplant Recipients

Clinical trial NCT05220397 · TERMINATED

Trial details

NCT number: NCT05220397
Sponsor: Mark Stegall
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Kidney Transplant Recipient

Start date: 2022-04-11
Primary completion: 2025-02-28
Enrollment: 468

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.